Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.264 | The impact of the eHealth app and the health management module: a retrospective data analysis and randomized controlled trial. |
Prof. WONG Chi Sang 黃至生教授 |
| 2022.255 | Prognostic implication of baseline and changes in liver stiffness measurement and the FibroScan-aspartate aminotransferase (FAST), Agile 3+ and Agile 4 scores in patients with non-alcoholic fatty liver disease: A retrospective cohort study |
Dr. WONG Vincent 黃煒燊 |
| 2022.226 | Endoscopic Image Recognition of Lesions Using Deep Learning |
Dr. REN Hongliang 任洪亮 |
| 2022.218 | A Pilot Study on Portable Surface Scanner | Prof. LAW Sheung Wai |
| 2022.225 | Sodium-Glucose Co-Transporter 2 Inhibitors Associated Diabetic Ketoacidosis: Incidence and Risk Factors, A Retrospective Cohort Study | Dr. CHOW Edith Wing Kar |
| 2022.215 | Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease: A Multicentre, Randomized, Double-masked, Placebo-controlled Clinical Trial |
Dr. CHONG Kam Lung 莊金隆 |
| 2022.224 | Longitudinal trends in outcomes of extracorporeal membrane oxygenation: a territory-wide observational study | Dr. LING Lowell |
| 2022.213 | Validation of C19-YRS in diagnosis of Long COVID syndrome in Chinese |
Dr. FAN Florence Sin Ying 樊倩英 |
| 2022.266 | To characterise the symptoms and gut microbiome for Long COVID in recovered COVID-19 survivors |
Prof. NG Siew Chien 黃秀娟 |
| 2022.216 | A Phase 1/2, Safety Confirmation, Placebo-controlled, Randomized Study of Nivolumab in Combination with Relatlimab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106) |
Prof. CHAN Stephen Lam 陳林 |
| 2022.212 | Impacts of COVID-19 vaccination on the ocular surface microbiota, cornea, uvea, macular vasculature and vision in children | Prof. YAM Jason Cheuk Sing |
| 2022.211 | Managment of Elderly Breast Cancer Patients - Surgery versus Conservative - a Retrospective Cohort in Hong Kong |
Dr. CHEUNG Alyson 張洛頤 |
| 2022.193 | A Pilot Study of Transforming the Prognosis and Care of Scoliosis with Artificial Intelligence (AI) assisted Curve Surveillance | Prof. LEE Wayne Yuk Wai |
| 2022.194 | Clinical outcome of Territory-wide Prehospital Stroke Notification in Hong Kong |
Dr. IP Bonaventure Yiu Ming 葉曜明 |
| 2022.196 | Genetic Landscape of Paediatric Idiopathic Steroid-Resistant Nephrotic Syndrome (SRNS) and Congenital or Infantile Nephrotic Syndrome (NS) in Hong Kong: A Retrospective Review | Dr. CHEUNG Hon Ming |
| 2022.170 | A prospective cross-sectional multi-center study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) for colorectal advanced neoplasia |
Prof. LAU Louis Ho Shing 柳浩城 |
| 2022.207 | The impact of early-life exposure to metabolic abnormalities on pubertal development - from epidemiological analyses to mechanisms |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2022.191 | Endovascular Embolization of Cerebral Arteriovenous Malformation, Cerebral Aneurysms, Dural Arteriovenous Fistula, and other Vascular Pathologies in Neurosurgery | Dr. CHEUNG Yuk Hong Eric |
| 2022.179 | Efficacy of digitally delivered and face-to-face group cognitive behavioural therapy for insomnia in pregnant women with comorbid insomnia and depression: A randomised controlled trial | Dr. CHAN Joey Wing Yan |
| 2022.195 | Individual Barriers & Reacceptance to Metabolic and Bariatric Surgery in Chinese Morbid Obesity Patients |
Dr. NG Stephen Ka Kei 吳家琦 |
| 2022.178 | Enhancing global self-esteem of breast cancer survivors: a randomized controlled trial | Prof. CHAIR Sek Ying |
| 2022.169 | The use of JAK-1/3 inhibitor (Tofacitinib) in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis – A pilot study |
Dr. CHAN Agnes Wai Sze 陳慧詩醫生 |
| 2022.171 | A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2022.167 | Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. |
Dr. KO Fanny Wai San 古惠珊 |
| 2022.166 | Diagnostic utility of Mycobacterium tuberculosis cell-free DNA (MTB cfDNA) in tuberculous and non-tuberculous pleural effusion |
Dr. CHAN Ka Pang 陳嘉鵬 |
| 2022.165 | A prospective study to identify known and unknown bacterial pathogens in patients with pleural infections using a combination of conventional culture and next-generation sequencing approaches |
Dr. CHAN Ka Pang 陳嘉鵬 |
| 2022.172 | KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2022.173 | EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation |
Prof. YEO Winnie 楊明明教授 |
| 2022.164 | A Study on Outcomes of Surgical and Percutaneous Left Atrial Appendage Closure |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.180 | Melanopsin-mediated pupillary response in patients with rapid eye movement sleep behaviour disorder | Dr. CHAN Joey Wing Yan |
| 2022.181 | Evaluation the effects of an online sleep and mood intervention in adults recovered from COVID-19 |
Dr. CHAN Ngan Yin 陳銀燕 |
| 2022.163 | Unraveling the regulatory effects of prodrug epigallocatechin-3-gallate on myeloid-derived suppresser cells to suppress the development of endometriosis |
Dr. ZHANG Tao 張濤 |
| 2022.201 | Territory-wide Retrospective Cohort Review of Paediatric Cardiomyopathy in Hong Kong | Dr. SO Enoch Chi Tak |
| 2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
| 2022.175 | Sequential TransArterial chemoembolization and stereotactic RadioTherapy Followed by Durvalumab (MEDI4736) and Tremelimumab for downstaging hepatocellular carcinoma for hepatectomy |
Prof. CHAN Stephen Lam 陳林醫生 |
| 2022.174 | AN OPEN LABEL, RANDOMISED, PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MTL-CEBPA ADMINISTERED IN COMBINATION WITH SORAFENIB OR SORAFENIB ALONE, IN TKI NAÏVE PARTICIPANTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS B OR HEPATITIS C VIRUS (OUTREACH2) |
Prof. CHAN Stephen Lam 陳林 |
| 2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.197 | Excess all-cause mortality during the COVID-19 pandemic in Hong Kong: A time series analysis using territory-wide hospitalization data | Dr. CHONG Ka Chun |
| 2022.198 | An audit of clinical outcomes of otology and neurotology surgeries in Hong Kong |
Dr. NG Iris Hoi Yee 伍凱怡 |
| 2022.183 | Online Mindfulness-based Intervention to Enhance Bracing Compliance for Adolescent Idiopathic Scoliosis (AIS) – A Pilot Randomized Single-blinded Controlled Trial |
Prof. LAM Tsz Ping 林子平 |
| 2022.202 | Real world analysis of sequencing of systemic treatment in hepatocellular carcinoma |
Prof. CHAN Stephen L. 陳林 |
| 2022.231 | A retrospective study on parental decisions following positive non-invasive prenatal testing of sex chromosome aneuploidies in Hong Kong | Prof. CHOY Kwong Wai |
| 2022.229 | Utilization of prenatal chromosomal microarray analysis (CMA) in prenatal diagnosis in Hong Kong | Prof. CHOY Kwong Wai |
| 2022.230 | Evaluation of clinical impact of public funded second-tier non-invasive prenatal testing (NIPT) in Hong Kong | Prof. CHOY Kwong Wai |
| 2022.203 | Altered gut microbiome composition by appendectomy contributes to colorectal cancer |
Prof. YU Jun 于君 |
| 2022.184 | Efficacy and Safety of an innovative Chinese Herbal formular for the Treatment of Gout: A Double-blind, Randomized, Placebo-Controlled Trial 一個創新中藥方劑作為治療痛風症之療效及安全性研究：隨機、雙盲、安慰劑對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2022.204 | Evalution of the Progression of Disease and Health-related Quality of Life in Ambulatory Heart Failure Patients: A local clinic-based registry |
Prof. TAN Guang Ming 譚廣明 |
| 2022.161 | Assessment of liver inflammation using glucose enhanced spin-lock T1rho MRI |
Prof. CHEN Weitian 陈蔚天 |
| 2022.205 | Retrospective review on paediatric and adolescent adnexal masses |
Dr. NG Karen 吳嘉詠 |
| 2022.190 | Individual patient data meta-analysis of medical treatment with timed surgery compared to immediate surgery in patients with acute type A intramural hematoma | Dr. CHOW Simon Chi Ying |
Page 31 of 254.